Virtual Tumor Board: Stage III ALK+ NSCLC Podcast

Podcast | English | 2025 | 48 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

This IASLC Virtual Tumor Board episode focuses on a patient with stage III ALK-positive NSCLC. ALK fusions are present in about 5% of NSCLC and there are now six ALK TKIs approved in the advanced setting. But how do we approach someone with earlier-stage disease?

Podcast Hosts:

Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Dwight Owen, MD, Associate Professor of Medicine, Ohio State University, James Comprehensive Cancer Center, Columbus, OH, USA
Maria Lucia Reale, MD, Thoracic Medical Oncologist, Vito Fazzi Hospital of Lecce, Italy